{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:03:49Z","timestamp":1780506229488,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03454-y","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:58:03Z","timestamp":1778878683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of Inhaled Natural Product Powders That Enhance Mucociliary Clearance"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6013-0770","authenticated-orcid":false,"given":"Dale J.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1028-134X","authenticated-orcid":false,"given":"Zachary","family":"Warnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6751-6883","authenticated-orcid":false,"given":"Daria","family":"Stoltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8166-1422","authenticated-orcid":false,"given":"Matthew","family":"Beerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6989-3439","authenticated-orcid":false,"given":"Norman","family":"Amparado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1567-7271","authenticated-orcid":false,"given":"Michael","family":"Grass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1356-6972","authenticated-orcid":false,"given":"Nicholas","family":"Haft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-0764","authenticated-orcid":false,"given":"Juan","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"3454_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1324552","volume":"15","author":"O Kayalar","year":"2024","unstructured":"Kayalar O, Rajabi H, Konyalilar N, Mortazavi D, Aksoy GT, Wang J, et al. Impact of particulate air pollution on airway injury and epithelial plasticity; underlying mechanisms. Front Immunol. 2024;15:1324552. https:\/\/doi.org\/10.3389\/fimmu.2024.1324552.","journal-title":"Front Immunol"},{"key":"3454_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.176413","volume":"954","author":"HC Taylor-Blair","year":"2024","unstructured":"Taylor-Blair HC, Siu ACW, Haysom-McDowell A, et al. Impact of airborne particulate matter-based pollution on the cellular and molecular mechanisms in chronic obstructive pulmonary disease. Sci Total Environ. 2024;954:176413.","journal-title":"Sci Total Environ"},{"key":"3454_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.scitotenv.2017.12.086","volume":"624","author":"WE Cascio","year":"2018","unstructured":"Cascio WE. Wildland fire smoke and human health. Sci Total Environ. 2018;624:586\u201395.","journal-title":"Sci Total Environ"},{"key":"3454_CR4","first-page":"792","volume":"116","author":"DG Fullerton","year":"2008","unstructured":"Fullerton DG, Bruce N, Gordon SB. Indoor air pollution from biomass fuel smoke is a major health concern. Environ Health Perspect. 2008;116:792\u20133.","journal-title":"Environ Health Perspect"},{"key":"3454_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/1759-7714.13323","volume":"11","author":"Y Cao","year":"2020","unstructured":"Cao Y, Chen M, Dong D, et al. Environmental pollutants damage airway epithelial cell cilia: implications for the prevention of obstructive lung diseases. Thorac Cancer. 2020;11:505\u201310.","journal-title":"Thorac Cancer"},{"key":"3454_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(24)02840-X","volume":"405","author":"GBD 2021 HAP Collaborators","year":"2025","unstructured":"GBD 2021 HAP Collaborators. Global, regional, and national burden of household air pollution, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2025;405:1167\u201381.","journal-title":"Lancet"},{"key":"3454_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11869-024-01664-6","volume":"18","author":"R Xu","year":"2025","unstructured":"Xu R, Stalter RM, Doubleday A, et al. Mortality associated with long-term PM2.5 exposure among overburdened communities in Washington State. Air Qual Atmos Health. 2025;18:1021\u201333.","journal-title":"Air Qual Atmos Health"},{"key":"3454_CR8","doi-asserted-by":"publisher","first-page":"e2020GH000359","DOI":"10.1029\/2020GH000359","volume":"5","author":"Y Liu","year":"2021","unstructured":"Liu Y, Austin E, Xiang J, et al. Health impact assessment of the 2020 Washington State wildfire smoke episode: excess health burden attributable to increased PM2.5 exposures and potential exposure reductions. Geohealth. 2021;5:e2020GH000359.","journal-title":"Geohealth"},{"key":"3454_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102380","volume":"99","author":"EC Willroth","year":"2024","unstructured":"Willroth EC, Pfund GN, Rule PD, Hill PL, John A, Kyle K, et al. A review of the literature on wellbeing and modifiable dementia risk factors. Ageing Res Rev. 2024;99:102380. https:\/\/doi.org\/10.1016\/j.arr.2024.102380.","journal-title":"Ageing Res Rev"},{"key":"3454_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.112581","volume":"208","author":"A Cristaldi","year":"2022","unstructured":"Cristaldi A, Fiore M, Oliveri Conti G, Pulvirenti E, Favara C, Grasso A, et al. Possible association between PM2.5 and neurodegenerative diseases: a systematic review. Environ Res. 2022;208:112581. https:\/\/doi.org\/10.1016\/j.envres.2021.112581.","journal-title":"Environ Res"},{"issue":"3","key":"3454_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220028120","volume":"120","author":"A Peters","year":"2023","unstructured":"Peters A. Ambient air pollution and Alzheimer\u2019s disease: the role of the composition of fine particles. Proc Natl Acad Sci U S A. 2023;120(3):e2220028120. https:\/\/doi.org\/10.1073\/pnas.2220028120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3454_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/ije\/dyz154","volume":"49","author":"SD Ilango","year":"2020","unstructured":"Ilango SD, Chen H, Hystad P, van Donkelaar A, Kwong JC, Tu K, et al. The role of cardiovascular disease in the relationship between air pollution and incident dementia: a population-based cohort study. Int J Epidemiol. 2020;49(1):36\u201344. https:\/\/doi.org\/10.1093\/ije\/dyz154.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"3454_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jamaneurol.2019.4914","volume":"77","author":"G Grande","year":"2020","unstructured":"Grande G, Ljungman PLS, Eneroth K, Bellander T, Rizzuto D. Association between cardiovascular disease and long-term exposure to air pollution with the risk of dementia. JAMA Neurol. 2020;77(7):801\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4914.","journal-title":"JAMA Neurol"},{"issue":"6","key":"3454_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/joim.13467","volume":"291","author":"J de Bont","year":"2022","unstructured":"de Bont J, Jaganathan S, Dahlquist M, Persson A, Stafoggia M, Ljungman P. Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. J Intern Med. 2022;291(6):779\u2013800. https:\/\/doi.org\/10.1111\/joim.13467.","journal-title":"J Intern Med"},{"issue":"14","key":"3454_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16142541","volume":"16","author":"S Jaganathan","year":"2019","unstructured":"Jaganathan S, Jaacks LM, Magsumbol M, Walia GK, Sieber NL, Shivasankar R, et al. Association of long-term exposure to fine particulate matter and cardio-metabolic diseases in low- and middle-income countries: a systematic review. Int J Environ Res Public Health. 2019;16(14):2541. https:\/\/doi.org\/10.3390\/ijerph16142541.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"3454_CR16","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1097\/HJH.0000000000000342","volume":"32","author":"R Liang","year":"2014","unstructured":"Liang R, Zhang B, Zhao X, Ruan Y, Lian H, Fan Z. Effect of exposure to PM2.5 on blood pressure: a systematic review and meta-analysis. J Hypertens. 2014;32(11):2130\u201340. https:\/\/doi.org\/10.1097\/HJH.0000000000000342.","journal-title":"J Hypertens"},{"issue":"4","key":"3454_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2022.4812","volume":"80","author":"T Yang","year":"2023","unstructured":"Yang T, Wang J, Huang J, Kelly FJ, Li G. Long-term exposure to multiple ambient air pollutants and association with incident depression and anxiety. JAMA Psychiat. 2023;80(4):305\u201313. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4812.","journal-title":"JAMA Psychiat"},{"issue":"12","key":"3454_CR18","doi-asserted-by":"publisher","DOI":"10.1289\/EHP4595","volume":"127","author":"I Braithwaite","year":"2019","unstructured":"Braithwaite I, Zhang S, Kirkbride JB, Osborn DPJ, Hayes JF. Air pollution (particulate matter) exposure and associations with depression, anxiety, bipolar, psychosis and suicide risk: a systematic review and meta-analysis. Environ Health Perspect. 2019;127(12):126002. https:\/\/doi.org\/10.1289\/EHP4595.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"3454_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/aje\/kwu341","volume":"181","author":"AV Bakian","year":"2015","unstructured":"Bakian AV, Huber RS, Coon H, Gray D, Wilson P, McMahon WM, et al. Acute air pollution exposure and risk of suicide completion. Am J Epidemiol. 2015;181(5):295\u2013303. https:\/\/doi.org\/10.1093\/aje\/kwu341.","journal-title":"Am J Epidemiol"},{"key":"3454_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.envres.2018.03.023","volume":"164","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2018","unstructured":"Calder\u00f3n-Garcidue\u00f1as L, Gonz\u00e1lez-Maciel A, Reynoso-Robles R, Delgado-Ch\u00e1vez R, Mukherjee PS, Kulesza RJ, et al. Hallmarks of Alzheimer disease are evolving relentlessly in Metropolitan Mexico City infants, children and young adults. APOE4 carriers have higher suicide risk and higher odds of reaching NFT stage V at \u226440 years of age. Environ Res. 2018;164:475\u201387. https:\/\/doi.org\/10.1016\/j.envres.2018.03.023.","journal-title":"Environ Res"},{"issue":"4","key":"3454_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3233\/JAD-231373","volume":"98","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2024","unstructured":"Calder\u00f3n-Garcidue\u00f1as L, Ayala A, Mukherjee PS. 2024 United States elections: air pollution, neurodegeneration, neuropsychiatric, and neurodevelopmental disorders. Who cares? J Alzheimers Dis. 2024;98(4):1277\u201382. https:\/\/doi.org\/10.3233\/JAD-231373.","journal-title":"J Alzheimers Dis"},{"issue":"Pt 4","key":"3454_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2025.122558","volume":"285","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2025","unstructured":"Calder\u00f3n-Garcidue\u00f1as L, Cejudo-Ruiz FR, Gonz\u00e1lez-Maciel A, Reynoso-Robles A, Ramos-Morales A, P\u00e9rez-Guille BE, et al. Cardiovascular damage, arrhythmogenesis and overlapping Alzheimer and Parkinson\u2019s diseases and TDP-43 pathology start in pediatric and young adult urban populations: magnetic ultrafine particulate matter and industrial particles with motion behavior play a key role. Environ Res. 2025;285(Pt 4):122558. https:\/\/doi.org\/10.1016\/j.envres.2025.122558.","journal-title":"Environ Res"},{"issue":"21","key":"3454_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101251","volume":"8","author":"YJ Kang","year":"2021","unstructured":"Kang YJ, Tan HY, Lee CY, Cho H. An air particulate pollutant induces neuroinflammation and neurodegeneration in human brain models. Adv Sci. 2021;8(21):e2101251. https:\/\/doi.org\/10.1002\/advs.202101251.","journal-title":"Adv Sci"},{"issue":"12","key":"3454_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124306","volume":"21","author":"O Hahad","year":"2020","unstructured":"Hahad O, Lelieveld J, Birklein F, Lieb K, Daiber A, M\u00fcnzel T. Ambient air pollution increases the risk of cerebrovascular and neuropsychiatric disorders through induction of inflammation and oxidative stress. Int J Mol Sci. 2020;21(12):4306. https:\/\/doi.org\/10.3390\/ijms21124306.","journal-title":"Int J Mol Sci"},{"key":"3454_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bj.2018.06.001","volume":"41","author":"J Kilian","year":"2018","unstructured":"Kilian J, Kitazawa M. The emerging risk of exposure to air pollution on cognitive decline and Alzheimer\u2019s disease: evidence from epidemiological and animal studies. Biomed J. 2018;41:141\u201362. https:\/\/doi.org\/10.1016\/j.bj.2018.06.001.","journal-title":"Biomed J"},{"key":"3454_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1165\/rcmb.2006-0082SF","volume":"35","author":"SH Randell","year":"2006","unstructured":"Randell SH, Boucher RC, University of North Carolina Virtual Lung Group. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol. 2006;35:20\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3454_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.chom.2016.01.001","volume":"19","author":"M Zanin","year":"2016","unstructured":"Zanin M, Baviskar P, Webster R, et al. The interaction between respiratory pathogens and mucus. Cell Host Microbe. 2016;19:159\u201368.","journal-title":"Cell Host Microbe"},{"key":"3454_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI0215217","volume":"109","author":"MR Knowles","year":"2002","unstructured":"Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002;109:571\u20137.","journal-title":"J Clin Invest"},{"issue":"Suppl 3","key":"3454_CR29","first-page":"S84","volume":"54","author":"CB Morrison","year":"2019","unstructured":"Morrison CB, Markovetz MR, Ehre C. Mucus, mucins, and cystic fibrosis. Pediatr Pulmonol. 2019;54(Suppl 3):S84\u201396.","journal-title":"Pediatr Pulmonol"},{"key":"3454_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0194-5998(98)70063-4","volume":"119","author":"T Runer","year":"1998","unstructured":"Runer T, Cervin A, Lindberg S, et al. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg. 1998;119:278\u201387.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3454_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0048-9697(89)90371-9","volume":"84","author":"B Holma","year":"1989","unstructured":"Holma B, Hegg PO. pH- and protein-dependent buffer capacity and viscosity of respiratory mucus. Their interrelationships and influence on health. Sci Total Environ. 1989;84:71\u201382. https:\/\/doi.org\/10.1016\/0048-9697(89)90371-9.","journal-title":"Sci Total Environ"},{"key":"3454_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1183\/09031936.98.11020330","volume":"11","author":"C Clary-Meinesz","year":"1998","unstructured":"Clary-Meinesz C, Mouroux J, Cosson J, Huitorel P, Blaive B. Influence of external pH on ciliary beat frequency in human bronchi and bronchioles. Eur Respir J. 1998;11:330\u20133. https:\/\/doi.org\/10.1183\/09031936.98.11020330.","journal-title":"Eur Respir J"},{"key":"3454_CR33","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1007\/s00018-015-1946-7","volume":"72","author":"A Ghosh","year":"2015","unstructured":"Ghosh A, Boucher RC, Tarran R. Airway hydration and COPD. Cell Mol Life Sci. 2015;72:3637\u201352.","journal-title":"Cell Mol Life Sci"},{"key":"3454_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/MDER.S48888","volume":"8","author":"M Ibrahim","year":"2015","unstructured":"Ibrahim M, Verma R, Garcia-Contreras L. Inhalation drug delivery devices: technology update. Med Devices (Auckl). 2015;8:131\u20139. https:\/\/doi.org\/10.2147\/MDER.S48888.","journal-title":"Med Devices (Auckl)"},{"key":"3454_CR35","volume-title":"A guide to aerosol delivery devices for respiratory therapists","author":"DS Gardenhire","year":"2017","unstructured":"Gardenhire DS, Burnett D, Strickland S, Myers TR. A guide to aerosol delivery devices for respiratory therapists. 4th ed. Irving: American Association for Respiratory Care; 2017.","edition":"4th ed"},{"issue":"12","key":"3454_CR36","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1007\/s11095-022-03363-2","volume":"39","author":"RYK Chang","year":"2022","unstructured":"Chang RYK, Chan HK. Advancements in particle engineering for inhalation delivery of small molecules and biotherapeutics. Pharm Res. 2022;39(12):3047\u201361. https:\/\/doi.org\/10.1007\/s11095-022-03363-2.","journal-title":"Pharm Res"},{"key":"3454_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122550","volume":"631","author":"L Mancini","year":"2023","unstructured":"Mancini L, Paolantoni M, Schoubben A, Ricci M. Development of spray-dried N-acetylcysteine dry powder for inhalation. Int J Pharm. 2023;631:122550. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122550.","journal-title":"Int J Pharm"},{"issue":"6","key":"3454_CR38","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/jps.21154","volume":"97","author":"R Westmeier","year":"2008","unstructured":"Westmeier R, Steckel H. Combination particles containing salmeterol xinafoate and fluticasone propionate: formulation and aerodynamic assessment. J Pharm Sci. 2008;97(6):2299\u2013310. https:\/\/doi.org\/10.1002\/jps.21154.","journal-title":"J Pharm Sci"},{"issue":"5","key":"3454_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17050622","volume":"17","author":"S Deshkar","year":"2025","unstructured":"Deshkar S, Vas A, Pagar R, Giram P, Thomas A, Undale V. Development of voriconazole proliposome based dry powder for inhalation: a design of experiment approach. Pharmaceutics. 2025;17(5):622. https:\/\/doi.org\/10.3390\/pharmaceutics17050622.","journal-title":"Pharmaceutics"},{"key":"3454_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119444","volume":"584","author":"Q Liao","year":"2020","unstructured":"Liao Q, Lam ICH, Lin HHS, Wan LTL, Lo JCK, Tai W, et al. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles. Int J Pharm. 2020;584:119444. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119444.","journal-title":"Int J Pharm"},{"issue":"52","key":"3454_CR41","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1016\/j.vaccine.2007.10.035","volume":"25","author":"JP Amorij","year":"2007","unstructured":"Amorij JP, Saluja V, Petersen AH, Hinrichs WLJ, Huckriede A, Frijlink HW. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB\/c mice. Vaccine. 2007;25(52):8707\u201317. https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.035.","journal-title":"Vaccine"},{"issue":"5","key":"3454_CR42","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/acs.molpharmaceut.8b00907","volume":"16","author":"C Moon","year":"2019","unstructured":"Moon C, Watts AB, Lu X, Su Y, Williams RO 3rd. Enhanced aerosolization of high potency nanoaggregates of voriconazole by dry powder inhalation. Mol Pharm. 2019;16(5):1799\u2013812. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00907.","journal-title":"Mol Pharm"},{"key":"3454_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122990","volume":"640","author":"YS Yu","year":"2023","unstructured":"Yu YS, AboulFotouh K, Xu H, Williams G, Suman J, Cano C, et al. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders. Int J Pharm. 2023;640:122990. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122990.","journal-title":"Int J Pharm"},{"key":"3454_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120701","volume":"603","author":"MO Jara","year":"2021","unstructured":"Jara MO, Warnken ZN, Sahakijpijarn S, Moon C, Maier EY, Christensen DJ, et al. Niclosamide inhalation powder made by thin-film freezing: multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters. Int J Pharm. 2021;603:120701. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120701.","journal-title":"Int J Pharm"},{"key":"3454_CR45","unstructured":"Williams RO III, Watts AB, Zhang Y, Sahakijpijarn S, Christensen D, Koleng JJ, Shetty S. Dry powder formulation of caveolin-1 peptides and methods of use thereof. US patent 12,280,089"},{"issue":"6","key":"3454_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10837450.2022.2098975","volume":"27","author":"X Ruan","year":"2022","unstructured":"Ruan X, Yu J, Miao H, Li R, Tong Z. Remdesivir powders manufactured by jet milling for potential pulmonary treatment of COVID-19. Pharm Dev Technol. 2022;27(6):635\u201345. https:\/\/doi.org\/10.1080\/10837450.2022.2098975.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"3454_CR47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/10837450.2025.2611906","volume":"31","author":"J Shi","year":"2026","unstructured":"Shi J, Miao H, Li C, Tong Z. A comparative study of spray drying and jet milling in the preparation of nintedanib dry powder for inhalation. Pharm Dev Technol. 2026;31(1):156\u201367. https:\/\/doi.org\/10.1080\/10837450.2025.2611906.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"3454_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010031","volume":"13","author":"B Chaurasiya","year":"2021","unstructured":"Chaurasiya B, Zhao YY. Dry powder for pulmonary delivery: a comprehensive review. Pharmaceutics. 2021;13(1):31. https:\/\/doi.org\/10.3390\/pharmaceutics13010031.","journal-title":"Pharmaceutics"},{"key":"3454_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/089426803769017668","volume":"16","author":"VA Marple","year":"2003","unstructured":"Marple VA, Olson BA, Santhanakrishnan K, et al. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: archival calibration. J Aerosol Med. 2003;16:301\u201324.","journal-title":"J Aerosol Med"},{"key":"3454_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/02786820300956","volume":"37","author":"PT O\u2019Shaughnessy","year":"2003","unstructured":"O\u2019Shaughnessy PT, Raabe OG. A comparison of cascade impactor data reduction methods. Aerosol Sci Technol. 2003;37:187\u2013200.","journal-title":"Aerosol Sci Technol"},{"key":"3454_CR51","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.tiv.2012.10.010","volume":"27","author":"S Huang","year":"2013","unstructured":"Huang S, Wiszniewski L, Constant S, et al. Potential of in vitro reconstituted 3D human airway epithelia (MucilAir\u2122) to assess respiratory sensitizers. Toxicol In Vitro. 2013;27:1151\u20136.","journal-title":"Toxicol In Vitro"},{"key":"3454_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/toxsci\/kfx255","volume":"162","author":"K Balogh Sivars","year":"2018","unstructured":"Balogh Sivars K, Sivars U, et al. A 3D human airway model enables prediction of respiratory toxicity of inhaled drugs in vitro. Toxicol Sci. 2018;162:301\u20138.","journal-title":"Toxicol Sci"},{"key":"3454_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/15376516.2016.1170251","volume":"26","author":"AR Iskandar","year":"2016","unstructured":"Iskandar AR, Gonzalez-Suarez I, Majeed S, et al. A framework for in vitro systems toxicology assessment of e-liquids. Toxicol Mech Methods. 2016;26:389\u2013413.","journal-title":"Toxicol Mech Methods"},{"key":"3454_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08958378.2017.1366602","volume":"29","author":"MP Walker","year":"2017","unstructured":"Walker MP, Cowlen M, Christensen D, et al. Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis. Inhal Toxicol. 2017;29:356\u201365.","journal-title":"Inhal Toxicol"},{"key":"3454_CR55","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1080\/08958370802207318","volume":"20","author":"DJ Alexander","year":"2008","unstructured":"Alexander DJ, Collins CJ, Coombs DW, et al. Association of inhalation toxicologists working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol. 2008;20:1179\u201389.","journal-title":"Inhal Toxicol"},{"key":"3454_CR56","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1091581815624080","volume":"35","author":"JS Tepper","year":"2016","unstructured":"Tepper JS, Kuehl PJ, Cracknell S, et al. Symposium summary: \u201cBreathe in, breathe out, it\u2019s easy: what you need to know about developing inhaled drugs.\u201d Int J Toxicol. 2016;35:376\u201392.","journal-title":"Int J Toxicol"},{"key":"3454_CR57","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1164\/rccm.201612-2445OC","volume":"196","author":"DW Scott","year":"2017","unstructured":"Scott DW, Walker MP, Sesma J, et al. SPX-101 is a novel epithelial sodium channel-targeted therapeutic for cystic fibrosis that restores mucus transport. Am J Respir Crit Care Med. 2017;196:734\u201344.","journal-title":"Am J Respir Crit Care Med"},{"key":"3454_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1165\/rcmb.2019-0287OC","volume":"63","author":"AT Adewale","year":"2020","unstructured":"Adewale AT, Falk Libby E, et al. Novel therapy of bicarbonate, glutathione, and ascorbic acid improves cystic fibrosis mucus transport. Am J Respir Cell Mol Biol. 2020;63:362\u201373.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03454-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03454-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:09:02Z","timestamp":1780502942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03454-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03454-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies described herein were funded by Climatic Health. DC is a shareholder of\/and receives consulting income from Climatic Health. DS receives consulting income from Climatic Health. NH is a shareholder of Climatic Health. No other authors have conflicts of interest with this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"213"}}